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Ataxia, from Greek meaning, “lack of order,” is described as irregular movement and 
discoordination of body, gait, eyes, and speech. Ataxia is associated with cerebellar damage 
due to stroke and other cerebellar pathologies. Ataxia frequently results in functional 
impairment. Standard physical and occupational therapies in stroke rehabilitation facilitate 
motor recovery, especially within 90 days. However, many patients experience movement 
derangements beyond this time frame. Rhythmic auditory stimulation has been shown to be 
an effective intervention in chronic motor deficits like those observed after cerebellar stroke. 
Efficacy among patients with chronic stroke-induced ataxia is unexplored. This randomized 
control trial seeks to determine the benefit of rhythmic auditory stimulation over standard of 
care for rehabilitation of cerebellar stroke-induced ataxia. Patient progress will be assessed 
using validated disability and ataxia scales. It is projected that rhythmic auditory stimulation 
will improve ataxia and independence among patients with chronic disability post-cerebellar 











































Ataxia characteristically causes a disruption of normal movement. Primary features 
of ataxia include changes in rate, quality, and performance of movement. Secondary 
characteristics include delayed movement initiation, inability to maintain consistent force, 
incoordination, dysmetria, and tremor. In a clinical setting, delayed movement initiation can 
be observed and detected in visuomotor tracking tasks. For example, during an examination, 
a patient is asked to use their index finger to mirror an examiner’s finger as sudden, rapid 
horizontal arm movements are made in the air. Patients may also exhibit delayed reaction 
times; depressed motor responses; and, an inability to maintain constant force. These deficits 
manifest as difficulty with isometric grip force; difficulty handling and lifting objects between 
fingers; and, impaired fine movements. Dysmetria is typified by undershooting or 
overshooting of intended limb positions, such as when approaching a target, and often 
involves misjudgments of distance or scale. When affecting the lower limbs, dysmetria 
causes under- and overstepping, influencing gait dynamics, balance, and posture. Involuntary 
rhythmic, oscillatory body movements are referred to as tremor; and, are often exaggerated 
during goal-directed movements. A heightened sensitivity of this intention-based tremor to 
movement leads to further deviations in coordination and movement synergy.1-6 
Motor impairments associated with ataxia are postulated to relate to loss of 
excitatory cerebellar input to the primary motor cortex in the cerebrum,7,8 as well as to 
disruptions of complex pathways involving analysis and prediction of movement.9,10 In 
patients with cerebellar stroke, ataxia has been associated with damage to specific vascular 
areas. Three paired arteries supply the cerebellum: the posterior inferior cerebellar artery 
(PICA), the anterior inferior cerebellar artery (AICA), and the superior cerebellar artery 




vertigo. Damage to the AICA is tied to dysmetria, Horner’s syndrome, unilateral hearing 
loss, and ipsilateral facial paralysis or anesthesia with contralateral hemi-body sensory 
loss.12,13 Damage to the SCA is most closely correlated with ataxia in cerebellar stroke 
patients. Lateralized cerebellar lesions generally produce ipsilateral motor dysfunctions, while 
diffuse lesions generate more symmetric derangements. Limb ataxia is noted to occur with 
damage to the cerebellar hemisphere, while isolated truncal and gait ataxia (with relative limb 
sparing) correlates with insult to the midline vermis.2 Due to vast heterogeneity in vascular 
organization between patients, presentations of cerebellar stroke often overlap regardless of 
implicated vessel, especially in the case of hemorrhagic infarcts.12 
On review of the literature on cerebellar stroke, some report that the PICA is the 
most commonly afflicted vascular territory, with estimates on PICA infarction ranging from 
49-63%.12 Damage to the SCA is thought to occur less frequently, with estimates 
approximating 16-18% of cerebellar stokes.14-16 Yet, competing research suggests that SCA 
infarction may be equally or more prevalent than PICA infarct.17 A minority of patients 
experience damage to two or more vascular regions. Regardless of affected territory, ataxia is 
the most commonly reported sign of cerebellar stroke, suggested by some reports to be 
present in 60 to nearly 100% of patients on presentation.11,18  
Gait ataxia is frequently observed in patients with cerebellar damage, and is defined 
by a stumbling walking pattern; irregular foot placement; increased variability in step time 
and length; widened stance; and, abnormal joint torque.19,20 Poor truncal motor control in 
ataxic patients contributes to gait abnormalities and loss of balance,21 whether cerebellar 
insult is due to vascular disease or to a hereditary condition. The heightened risk of falls in 





1.2 Cerebellar stroke  
 
Each year, nearly 800,000 people in the United States are affected by stroke.25 Of 
these, approximately 2-3% occur in the cerebellum.12 Though a fraction of the size of the 
cerebrum, the cerebellum contains nearly 80% of the brain’s neurons. It is believed to play a 
vital role in regulation of muscle tone and motor coordination, timing, and learning.26 As 
with a cerebrovascular accident (CVA) in the cerebrum, a stroke in the cerebellum may be 
ischemic or hemorrhagic, both of which may lead to potentially devastating effects.  
Despite the relatively low percentage of total strokes, cerebellar infarcts are 
associated with a disproportionate amount of morbidity and mortality.27 Vasogenic edema is 
a complication in 17-54% of cerebellar stroke patients,28 potentially causing numerous life-
threatening complications such as hydrocephalus; compression of the midbrain and pons; 
upward herniation of the superior vermis cerebelli through the tentorial notch; or, 
downward herniation of the cerebellar tonsils through the foramen magnum.28 Risk of 
complication is increased by delayed or missed diagnosis. 
Presentation of acute cerebellar stroke is often non-specific, with symptoms such as 
dizziness, headache, nausea, vomiting, vertigo, or unsteady gait.11 Ataxia, with its 
characteristically distorted motor patterns, is believed to occur in 40-97% of patients during 
the acute or subacute period after cerebellar stroke.11,13,29,30 Additionally, initial diagnostic 
workup utilizing CT scan is often inadequate for detection of cerebellar infarcts.16 Magnetic 
resonance imaging with diffusion weighted imaging (DW-MRI) remains the gold standard12, 
but this is rarely the first modality used to evaluate stroke. There may be a failure to 
recognize stroke symptoms or an inability to obtain a good neurological examination, 




Patients with cerebellar stroke who experience complications like hydrocephalus, 
brainstem compression, or herniation are more likely to undergo surgery and have poor 
outcomes than patients without such complications.28,31,32 Those with more complex strokes 
often have persistent deficits in motor coordination and functional independence.13,14,17 Gait 
ataxia is a frequent sign in patients with acute cerebellar stroke.18 Studies suggest that ataxic 
gait persists in 20-50% of patients as a long-term functional disability.13,17,31,33 Patients who 
survive are often at increased risk of falls and fear of falling.34 Stroke patients who fall are 
twice as likely to sustain hip fracture compared to non-stroke patients.35 
 
1.3 Motor recovery following stroke 
 
 Evidence on long-term functional outcomes following cerebellar stroke is scarce, but 
existing research suggests that many patients continue to suffer chronic motor derangements 
and functional impairment despite standard rehabilitation.14,17,28,31,36 It has been observed that 
motor recovery following cerebral strokes show a plateau in functional gains after a 90-day 
acute period.37-40 The persistence of motor dysfunction appears to be more common in 
strokes with more severe injury at onset, e.g. larger infarcts, hemorrhagic strokes, and those 
with complications such as edema or herniation.17,41 Many patients with chronic post-stroke 
motor impairments suffer reductions in functional independence, which is closely associated 
with the ability to ambulate independently.42 
 
1.4 Traditional stroke rehabilitation  
 
There is a certain level of complexity to conducting large scale, rigorous clinical trials 
evaluating the efficacy of rehabilitation modalities. Aside from identifying an appropriate 
cohort group amongst a heterogeneous post-stroke population, there are vast differences in 




in intensity, duration, and type of intervention, as well as degree of specialist involvement. 
With regards to specific therapeutic interventions for ataxia, investigations have focused on 
biofeedback; constraint-induced movement therapy; treadmill training; and, other 
innovations designed to facilitate motor recovery in stroke patients.44 While many of these 
modalities appear promising, research has yet to provide evidence from adequately powered 
randomized control trials to indicate superiority of any novel methodology over another.45 
The American Heart Association/American Stroke Association (AHA/ASA) 
guidelines provide traditional physical therapy (PT), occupational therapy (OT), and speech 
language therapy (SLT) for stroke patients to foster improvement of balance and walking, 
task-specific functional independence, and communication, respectively. These practices are 
the standard of care for stroke rehabilitation,30 and are directed toward improvements in 
limb weakness, paralysis, and aphasia. Current research has failed to demonstrate efficacy of 
any one form of physical therapy over another, whether in cerebral or cerebellar stroke.46 
Research indicates that the time between stroke onset and initiation of rehabilitation 
is crucial to maximize recovery outcomes. Specifically, distinctions have been made between 
functional gains made during the acute versus chronic stages of stroke. Rehabilitation within 
the acute period of time, defined up to 90 days, has shown the greatest amount of functional 
improvement.37,38,47 Part of this immediate recovery is attributed to natural internal healing 
mechanisms, postulated to involve neural reorganization and compensatory input from non-
damaged brain areas.48 Motor improvements are facilitated through the use of rehabilitation 
techniques including PT, OT, and SLT, based on the clinical needs of the patient.44 Beyond 
90 days, formal PT and OT, as well as home-based aerobic and training programs, have been 
implemented for patients with persisting deficits.45 Benefits of continuing interventions are 




It is unclear whether recovery differs between cerebral and cerebellar stroke. No 
separate standard of care exists for rehabilitation based on stroke location. Little definitive 
conclusion has been drawn regarding prognostic factors other than that greater functional 
impairment on admission and concurrent hemiparesis are linked to ataxia and poorer 
functional recovery after the acute period.15,29 Additionally, SCA-related infarcts and those 
presenting with altered mental status appear to correlate inversely with functional recovery. 
The cause of this finding is believed to relate to edema causing brain stem compression and 
hydrocephalus, and is generally seen when larger territories are impacted by stroke.15 In the 
cerebellum, lesion site may substantially influence outcomes for patients with cerebellar 
stroke, regardless of the dimensions of the impacted territory.49 And, those with hemorrhagic 
lesions suffer more functional impairment compared to those with ischemic damage.15 
 
1.5 Music therapy  
 
Music therapy is an emerging rehabilitative field that has been used to augment 
recovery in motor pathologies including stroke and degenerative cerebellar disorders.50,51 
Implemented by a board certified music therapist, music therapy is a broad field including 
techniques such as rhythmic auditory stimulation or cueing (RAS/C), music supported 
therapy (MST), and patterned sensory enhancement (PSE).52 The mechanisms by which 
music therapy works to facilitate motor recovery are thought to involve neuroplasticity, 
emotional motivational effects, and entrainment of rhythmic auditory cues.53,54 
The act of playing and making music incorporates inputs from auditory, sensory, and 
motor areas of the brain, and stimulates neuroplasticity.53,55 Dynamic relationships between 
audio and motor regions appear to be enhanced by emotional and motivational relevance of 




patients train using the affected limb, have shown enhanced neuroplasticity in recovery for 
acute and chronic stroke patients.53,56,57 Audio-motor coupling and enhanced synchronization 
of brain areas are thought to contribute to motor recovery in patients who undergo RAS 
training,58 which uses external rhythmic auditory cues to promote gait recovery.  
 
1.6 Music therapy in stroke rehabilitation 
  
To date, music therapy for motor difficulties after stroke has been reported primarily 
in cerebral stroke with residual hemiparesis.59-62 Studies on MST are largely focused on 
recovery of upper extremity function. RAS has been utilized for gait enhancement in patients 
with acute and chronic abnormalities in gait, posture, and balance.51,62 In patients with 
impaired gait patterns after stroke, use of RAS has produced improvements in gait velocity, 
stride length, and cadence.60,63,64 Compared to rehabilitative strategies such as treadmill 
training (TT) or neurodevelopmental (NDT)/Bobath training (a widely-implemented post-
stroke physical rehabilitation approach),65 RAS has produced superior gains in gait 
parameters.51,60 Electromyography (EMG) of muscle activation in stroke patients has shown 
reduced amplitude variability with RAS, suggesting that rhythmic cues promote consistent 
timing and uniform motor recruitment through central mechanisms of action.59,62,64 
Use of RAS in gait rehabilitation is thought to facilitate entrainment, the process by 
which the oscillatory frequency of an external stimulus is adopted by a “weaker” oscillator, 
producing synchronization of movements with the provided rhythm.66 In the context of 
neuropathological processes and motor abnormalities, the weaker oscillator caused by brain 
injury, becomes entrained to externally cued rhythms of a metronome or music via 
proprioceptive feedback mechanisms. It has been suggested that the auditory feedback of 




proprioceptive reafference. Through practice and repetition, discrepancy between footfall 
and auditory rhythm is minimized, eventually promoting a more stable, regular gait.67  
There is little research on music therapy in cerebellar stroke and associated ataxia. 
Most of the literature on music therapy and gait focuses on patients with hemispheric stroke. 
Outcomes addressed in these studies include gait speed and symmetry. These metrics are 
subject to impairment in ataxia. Improvements in these metrics are promising for extension 
of RAS to patients with cerebellar stroke.68 Few studies have explored the use of music 
therapy in relation to lesion site; yet, a small body of evidence suggests that motor deficits 
induced by cerebellar lesions are amenable to improvement with RAS.64  
 
1.7 Music therapy outside of stroke 
 
Music therapy has been explored as an intervention for other motor disorders.69 A 
large portion of work on RAS has focused on its use among patients with Parkinson’s 
disease (PD), as well as multiple sclerosis (MS), cerebral palsy (CP), and Huntington’s disease 
(HD).50,64,70 These disorders manifest similar dysfunctions in gait and movement, and parallel 
many motor impairments seen in stroke, despite the unique pathological etiologies of deficit.  
In patients with PD, changes in motor function include tremor, rigidity, akinesia, 
bradykinesia, and postural instability.71 These symptoms are comparable to motor 
abnormalities seen in HD and MS patients. These patients may experience an inability to 
ambulate normally due to tremor, spasticity, ataxia, and disequilibrium.72 Patients with CP 
share analogous motor impairments involving postural instability and dystonia (abnormal 
muscular contractures) and joint subluxation.  
Patients with motor abnormalities and gait impairment due to these pathologies have 




With use of RAS, patients with PD and MS have shown measurable increases in stride length 
and swing time, which clinically fosters a reduction in falls.50,75 Freezing of gait, seen in 
patients with PD, appears amenable to improvement with use of RAS as well.78 Patients with 
CP and dysfunctional joint flexion and contractures have experienced amelioration of 
abnormalities with RAS training.79,80 Patients with HD have demonstrated improvements in 
walking speed with RAS.81 
Due to observed parallels between cerebellar stroke-induced motor abnormalities 
and those seen in PD, MS, CP, and HD, the use of RAS in cerebellar stroke is promising. It 
remains unclear whether motor dysfunction and gait impairment in patients with chronic 
cerebellar stroke is amenable to improvement with RAS. Analyses of gait impairments in 
patients with PD indicate distinct spatiotemporal irregularities compared to patients with 
cerebellar ataxia.82,83 One can speculate whether neuroplasticity offers partial compensation 
by recruiting healthy cerebellar networks in these patients.50 It is possible that similar RAS-
facilitated therapies will result in comparable improvements in those with cerebellar stroke. 
 
1.8 Statement of the problem 
 
Wide gaps exist in the research of long-term outcomes and rehabilitative strategies 
for patients with chronic cerebellar stroke. Many experience persistent ataxic gait 
impairments and functional deficits. Little work has assessed therapeutic interventions in this 
specific group. Available studies fall short of adequately operationalizing ataxia using 
clinically validated scales. While rehabilitation utilizing PT and OT remains the standard of 
care for stroke, these therapies are limited in producing motor recovery after an acute period 
of 90 days, and potential benefits of other approaches remain unexplored or inconclusive. 




motor deficits due to stroke. RAS is associated with gait improvement in acute and chronic 
stroke patients, as well as in patients with neurological disorders such as PD, MS, CP, and 
HD. The adoption of RAS, and implications and possible benefits for RAS in patients with 
chronic post-stroke cerebellar ataxia, warrants additional clinical investigation. 
 
1.9 Goals and objectives 
 
The proposed study seeks to explore how rhythmic auditory stimulation compares to 
the standard of care (PT/OT) in outcomes of 1) improvement in ataxia and 2) improvement 
in functional independence, for patients with chronic ataxia following cerebellar stroke. 
Subjects will be randomized to interventions, either RAS or standard of care (PT/OT). They 
will participate in regularly scheduled therapy and undergo rating with the use of the two 
scales: Scale for the Assessment and Rating of Ataxia (SARA) and Modified Rankin Scale 
(mRS). Data will be collected over six months. It is anticipated that those who undergo 
intervention with RAS will demonstrate superior improvements in ataxia and functional 
independence, compared to those receiving standard of care rehabilitation techniques. Thus, 
RAS may hold potential as an approach to continued motor rehabilitation during a period of 




The implementation of RAS therapy over six months for patients with chronic ataxia 
and functional impairment post-cerebellar stroke, will produce a difference in the proportion 
of patients who achieve functional independence as measured by the Modified Rankin scale 
(mRS); and, change in ataxic symptoms as assessed by the Scale for Assessment and Rating 







Acute: definition of the acute period following stroke lacks standardization across studies. 
For the purpose of this study, the acute period refers to the first 90 days after stroke onset, 
as it is generally agreed upon that the majority of motor recovery occurs during this time.37,38 
Chronic: the chronic phase of stroke is defined here as the time beyond 90 days from stroke 
onset, during which time persistent ataxia and functional deficits have been noted.13,14,68,84 
Cerebellar stroke: cerebellar stroke is defined as ischemic or hemorrhagic cerebrovascular 
accident originating from damage to the vascular structures of the cerebellum.12 Lesions may 
be embolic, thrombotic, or originating from vascular dissection or small artery disease.11 
Ataxia: ataxia is a clinical sign characterized by delayed initiation of movement, inability to 
maintain consistent force, incoordination, dysmetria, and tremor.1-4 Clinically validated scales 
for assessment of ataxia include the Scale for the Assessment and Rating of Ataxia (SARA) 
and International Cooperative Ataxia Rating Scale (ICARS).68,85  
Rhythmic Auditory Stimulation (RAS): a subcategory of music therapy, RAS is a motor 
rehabilitation technique requiring participants to walk to the beat of a metronome or 
rhythmically-enhanced music. Cue frequency may be adjusted according to patient ability.50,59 
Standard of care: the standard of care for stroke rehabilitation consists of a multimodal 
approach incorporating physical therapy (PT), occupational therapy (OT), and speech 
language therapy (SLT).30 Within this study, which focuses on motor performance and 
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2.1 Review of Relevant Literature 
 
2.1.1 The functional cerebellum 
 
Anatomical organization of cerebellar circuits and their involvement in motor 
function is complex. We will first outline the role of the cerebellum in movement to facilitate 
understanding of the chronic motor deficits experienced by patients after cerebellar stroke. 
To simplify the systems of cerebellar function, two pathways may be observed: the afferent 
cortico-cerebellar-cortical circuit, and the efferent the dento-rubro-olivary circuit.86   
The cortico-cerebellar-cortical circuit is comprised of afferent fibers from the frontal 
lobe, which travel to the cerebellar cortex via the middle cerebellar peduncle. Disruption of 
afferent signals from the frontal lobe is associated with metabolic depression of the 
contralateral cerebellar hemisphere.87,88 Within the circuit, the dentato-rubro-thalamo-cortical 
tract conducts signals from the cerebellum. In this pathway, originating neurons travel from 
the dentate nucleus, through the superior cerebellar peduncle to contralateral red nucleus 
and ventrolateral thalamus, and finally to the motor cortex. Efferent signaling to the primary 
motor cortex has historically been considered the primary mechanism by which the 
cerebellum influences movement, but recent work suggests contributions from premotor 
cortical areas and regions of the basal ganglia.89 The dento-rubro-olivary circuit, also known 
as the Guillain-Mollaret triangle, is comprised of efferent fibers from the dentate nucleus, 
which pass through the superior cerebellar peduncle to synapse on the contralateral red 
nucleus. Efferent fibers from the red nucleus synapse with the inferior olivary nucleus, 
which signals through the inferior cerebellar peduncle to synapse on the contralateral 
cerebellum. The triangle acts as a regulatory feedback loop for motor activity.86 
 In recent years, conceptual theories on the ways in which cerebellar organization 




the forward model, theorizes that the cerebellum is responsible for the processing of state-
dependent movement; that is, the prediction of sensory consequences of movement. These 
elements of movement include factors such as position or velocity, and calculation of 
estimations for the next state.9 The second, inverse model, suggests that the cerebellum is an 
orchestrator of motor commands and explicit production of state changes, directly 
influencing motor commands to match desired sensory outcomes.9,10  
The two models are proposed to work both independently and in tandem.92 Work by 
Jueptner et al. (1997) undertook to explore the relative contributions of the cerebellum in 
processing sensory information versus active participation in movement generation. Using 
positron emission tomography (PET) to measure regional cerebral blood flow (rCBF), 
researchers compared local and spatial extents of cerebellar activation during active arm 
movement, passive arm movement, imagined motion, and actual motion. Measurements of 
local extent (as determined by % increase in rCBF at a location) and spatial extent (as 
determined by voxels) were nearly identical between active and passive arm movement (p > 
0.05), with only 12% more neuronal activity measured during active movement. This 
suggests a predominant role for the cerebellum in sensory processing. Similarly, imagined 
movements were associated with increases in rCBF in the neocerebellar hemisphere and 
vermis of the posterior lobe. This suggests a role for the cerebellum in movement planning.93 
 Motor outputs associated with the cerebellum are postulated to involve sensory 
integration of timing and coordination.94 Time-dependent control relies on the accurate 
assessment of temporal intervals between sensory stimuli. Movement coordination is 
associated with state-dependent control, using estimates of body position and motion to 
determine future motion. Research by Diedrichsen and colleagues attempted to delineate 




precise motor commands. Using functional magnetic resonance imaging (fMRI), they 
observed that altering the temporal distance between tasks varied the performance of spaced 
motor tasks such as the movement of a motor arm and an isometric thumb press. Timing of 
the thumb press was consistent with a time-dependent control hypothesis when the tasks did 
not overlap (t(5) = 2.71; p = 0.04). When tasks overlapped, changing the speed of the motor 
arm produced a timing change in the thumb press, as predicted by a state-dependent control 
hypothesis (t(5) > 2.57; p < 0.05). And, fMRI indicated robust cerebellar activation only with 
state-dependent control, suggesting a role for the cerebellum in estimations of state and 
organization as it pertains to coordination.95 Thus, the cerebellum has been associated with 
error detection and determination of sensory discrepancies between predicted and actual 
consequences of movement as state-dependent control mechanisms. Blakemore et al. (2001) 
then used PET to measure rCBF to observe increased cerebellar activation when patients 
encountered a delay between self-produced hand movement and externally-produced tactile 
stimulation (p < 0.05). Increasing differences in temporal correspondence (between 
movement and stimulation) correlated to greater cerebellar activation, suggesting increasing 
inaccuracy of the forward model’s sensory prediction.  
 
2.1.2 Cerebellar dysfunction 
 
A large body of research conducted to broaden the understanding of the cerebellum 
is based on case studies using patients with focal cerebellar injuries. In the context of chronic 
cerebellar stroke, abnormal movement patterns and motor dysfunction have been frequently 
observed.96 One of the more familiar of these works was published by Gordon Holmes in 
1917. Presenting patients with cerebellar gunshot injuries, he observed unilateral muscle 




tremor; and, dysmetria.97 Cerebellar abnormalities due to various pathologies such as stroke, 
malignancy, multiple sclerosis, and spinocerebellar ataxias shared similar motor dysfunctions. 
The irregular limb movements of ataxia permeated to gait instability, incoordination, slurred 
speech, and nystagmus.98 While ataxia is frequently observed following cerebellar stroke, few 
studies have directly addressed the prevalence of ataxia in the chronic phase. 
In addition to abnormalities in motor execution, cerebellar damage has been linked 
with deficits in procedural learning.99 Doyon et al. (1997) explored the role of the cerebellum 
by comparing performance of patients with Parkinson’s disease (PD), cerebellar damage, and 
frontal lobe lesions, against healthy controls. Patients with cerebellar damage and those with 
severe PD were impaired during the late stages of acquisition of a visuomotor sequence and 
failed to improve with time as compared to healthy controls [F(2,44) = 9.81, p < 0.001]. The 
findings suggested that patients with cerebellar damage and PD fail in aspects of learning 
related to automatization and fine-tuning of movement.100 Similar findings were reported by 
Lang et al. (2002), when comparing patients with cerebellar damage to healthy controls in 
performance of single and dual motor tasks. Echoing conclusions by Doyon et al. in 1997, 
patients in the cerebellar group performed poorly in comparison to controls (p < 0.001) 
when addressing components of automaticity such as movement completion and error.101  
Interruption of visuomotor integration in patients with cerebellar damage does not 
appear to resolve. Work by Gómez-Beldarrain et al. (1998) explored effects of chronic focal 
cerebellar lesions on procedural motor learning using the serial timed reaction task (SRTT). 
Findings indicated that at 29 months ( 22 months, range 6-66 months) as a mean time from 
unilateral cerebellar stroke, patients displayed a lack of procedural learning when using the 
ipsilesional hand to complete the SRTT versus controls (p < 0.005). Results were universal 




 Boyd and Winstein (2004) additionally observed non-resolving impairments in timing 
prediction by patients with chronic cerebellar stroke, despite preserved spatial accuracy. 
Stroke patients were assessed for differences in motor performance across practice sessions 
and at a retention test. Cerebellar patients and controls demonstrated reduced tracking errors 
over the practice period, but patients with chronic cerebellar lesions were unable to reduce 
lag time of tracking across sessions and at retention testing (p = 0.270). This suggests 
persistent temporal impairment, despite preserved accuracy in spatial tracking.103 
 
2.1.3 Functional impairment and ataxia in chronic cerebellar stroke  
The complex interplay between excitatory and inhibitory cerebellar pathways limits 
understanding of the precise mechanism by which stroke induces ataxia. Yet, chronic motor 
dysfunction after cerebellar stroke is thought to be tied to persistent disruption of networks 
between the cerebellum and the primary motor cortex (M1). Such findings were observed by 
Farias da Guarda et al. (2010), using transcranial magnetic stimulation (TMS) in patients with 
unilateral chronic cerebellar stroke to induce asymmetrical hemispheric excitation and to 
decrease short interval intracortical inhibition (SICI) in the contralesional M1, compared to 
the ipsilesional M1 and healthy controls (p = 0.048). Effects were notable for increased 
motor dexterity associated with decreased SICI (p = 0.003).8 Using cerebellar intermittent 
theta burst stimulation (iTBS), Bonnì et al. (2014) modulated cortical-cerebellar pathways in 
patients with cerebellar injury, noting decreased cerebellar brain inhibition (p = 0.03) and 
increased intracortical facilitation (p < 0.05) compared to pre-iTBS recordings. Findings 
were accompanied by significant improvements in the posture and gait subscales of the 
modified ICARS (mICARS) (Wilcoxon test p = 0.02).104 These observations indicate that 




Despite the prevalence of ataxia in patients presenting with cerebellar stroke, there 
have been few additional studies in this population. Research on ataxia has focused on 
observations of motor recovery during the acute phase of stroke, but fails to operationalize 
data using clinically validated ataxia scales such as the SARA or ICARS. Work by Chua and 
Kong (1997) explored functional outcomes in patients with brain stem stroke, observing 
significant improvements after rehabilitation programs, with nearly half of patients deemed 
“severely ataxic” upon admission and “mildly ataxic” upon discharge (p <0.001).29  
Similar improvements were seen using the modified ICARS (mICARS) in work by 
Nickel et al. (2018), which assessed 15 cerebellar stroke patients throughout a 90-day acute 
recovery period. While noting substantial recovery of ataxia during this time, the study was 
limited by its inclusion only of patients with ischemic stroke, mostly isolated to the PICA 
region, with no brainstem involvement, and small lesion sizes41 (median size reported by 
Nickel was 3.4 cm3, while lesions >20 cm3 have been noted in other studies).33 A study by 
Bultmann et al. (2014) included cerebellar stroke patients with a mean lesion volume over 
two times that reported by Nickel et al. (2018) and found that patients with cerebellar stroke 
continued to suffer gait-related ataxic symptoms at 90 days post-stroke. They experienced 
persistent impairments in total ICARS, ICARS gait subscale, ICARS lower limb subscale (p 
= 0.04, p = 0.02, p = 0.04), and gait speed (p =0.002).13 
Regarding functional impairment, studies document residual deficits after a 90-day 
recovery period. In a multicenter study of nearly 300 cerebellar stroke patients, Tohgi et al. 
(1993) performed a 5-year review regarding clinical and prognostic factors and documented 
classified functional outcomes at 3 months post-stroke. The study included patients with 
infarctions in the SCA (52%), PICA (49%), and AICA (20%) vascular regions, and those 




were classified as independent; 21% as dependent; 4% as bedridden; and, 5% had died. Of 
those with lesions to single vascular regions, researchers noted lower rates of independence 
in patients with SCA infarction (p < 0.005), as well as those with multiple vessels involved. 
Prognosis was worse for patients with poorer levels of consciousness on admission. Patients 
who underwent surgery were nearly split between independent and dependent outcomes.17 
A number of smaller studies on long-term outcomes of cerebellar stroke have similar 
findings to those observed by Tohgi and colleagues. Much of this work has used the 
Modified Rankin Scale (mRS), which classifies patients according to disability and ability to 
walk and perform activities of daily life, from 0-6 points.42 A score of 0 indicates perfect 
health and absence of symptoms. Scores of 1-5 correlate with increasing disability, meaning 
an ability to carry out dependent and independent activities of daily living, and walk without 
assistance. A score of 6 is given to patients who have died. 42 Among stroke patients, 
categorization is often dichotomized, with a score of 0-2 indicative of relatively “good 
outcome”, while scores of 3-5 are used to indicate “poor outcome.”105  
Ng et al. (2015) reviewed 79 cases of patients with hemorrhagic or ischemic 
cerebellar stroke, and calculated mRS scores at 3 and 6 months. Analysis of prognostic 
factors found better outcomes with smaller, non-hemorrhagic strokes.33 Calic et al. (2015) 
echoed findings on the differential prognostic implications of small (<2 cm3) versus large ( 
2 cm3) cerebellar infarctions, with better outcomes (mRS = 0-2) tied to smaller lesions (OR 
3.97, 95% CI 1.41–11.15; p = 0.01).36 Similar results were seen by Juttler et al. (2009) in a 
study of long-term outcomes of 56 patients treated surgically for space-occupying cerebellar 
infarction up to 8 years from stroke;28 Pfefferkorn et al. (2009) in observing outcomes after 
suboccipital decompressive craniectomy for cerebellar infarction up to 11 years post-stroke;31 




Many interrelated prognostic factors have been suggested to correlate with poor 
functional outcomes in patients with cerebellar stroke. These include hemorrhage versus 
ischemia; vascular territory; edema; brain stem involvement; herniation; and, hydrocephalus.  
 
2.1.4 The challenge of rehabilitation in chronic stroke  
Persistent functional impairments after an acute recovery period aligns with reports 
of patients with cerebral stroke. Plateaus in recovery after the acute period result in chronic 
cerebellar impairments, often in gait and functionality. Current research on long-term 
outcomes tends to focus on lower limb function and gait. Head-to-head comparison of 
outcomes amongst studies of long-term ataxia and functional impairment lacks 
standardization, making comparisons limited. 
A large scale, prospective evaluation of recovery of walking ability in stroke patients 
was conducted by Jørgensen and colleagues (1995), with 804 patients with acute stroke 
undergoing rehabilitation. Jørgensen’s team used the Bobath concept (a widely-utilized 
physiotherapy approach for patients with motor dysfunction in hemiplegic stroke)106 and the 
Barthel Index (BI) (a scale delineating independence, assistance-needed, and non-ambulatory 
states). Of the non-ambulatory patients on admission, 80% reached best walking function 
within 6 weeks, and 95% reached it within 11 weeks. For patients needing assistance, similar 
trends were seen, with 80% reaching best function within 3 weeks, and 95% within 5 weeks. 
Of all patients admitted with impaired ambulation (non-ambulatory or assistance-needed), 
33% improved, 33% failed to improve, 1% deteriorated, and 33% died.38 
A prospective 6-month study of functional recovery in acute stroke patients was 
implemented by Lee et al. (2015), using regular interventions and re-assessments by physical, 




sensorimotor function, Functional Ambulation Category (FAC) of walking independence, 
Trunk Impairment Scale (TIS), Modified Barthel Index (MBI), and Mini-Mental State 
Examination (MMSE). Improvement in all outcomes occurred between study initiation and 
6-month follow-up, with significant interactions between time points and recovery measures 
(p < 0.001). Findings did reflect a plateau in the Fugl-Meyer Assessment, with little 
improvement between 3 and 6 months (p  0.05). Interestingly, FAC and MBI scores 
(reflecting gait and functional ability) documented improvements up to 6 months. Of note, 
patients in the study were fewer (n = 20 at 6-month follow up) and younger (mean age = 
53.3 years) than those of many previously mentioned studies.  
 A systematic review by Pollock et al. (2014) attempted to delineate between physical 
rehabilitation approaches in recovery of function and mobility post-stroke. Outcomes such 
as independence in activities of daily living (ADLs), motor function, balance, gait velocity, 
and length of stay were assessed. After analysis of nearly 100 studies, pooled results revealed 
no significant differences between approaches in improving independence in ADLs (p = 
0.71) or motor function (p = 0.41). These findings illustrate an association between chronic, 
persistent post-stroke effects on motor (p = 0.05) and functional (p = 0.003) recovery, 
consistent with other findings on stroke outcomes,46 irrespective of rehabilitation technique. 
 
2.1.5 Music therapy in stroke rehabilitation 
 
Music-based therapies are a promising new approach to stroke rehabilitation, in both 
the acute and chronic setting. The lack of effective PT and OT for improving chronic ataxia 
and functional dependence in post-stroke patients has inspired research in alternative 
treatments like music therapy. Investigations regarding the most effective techniques have 




patterned sensory enhancement (PSE); and, therapeutic instrument playing (TIMP) for 
recovery of upper extremity function.107 Musical intonation therapy (MIT) and musical 
neglect training (MNT) have been utilized for recovery of speech and language deficits, as 
well as hemispatial neglect.108 Rhythmic auditory stimulation (RAS) using metronome beats 
or music tailored to walking cadence has shown benefits for recovery of functional gait.  
Due to the technique’s novelty, evidence for RAS in chronic stroke is limited, and 
existing work has been largely confined to cerebral stroke. Outcomes have included the 
Timed Get Up and Go test, Berg Balance Scale, and Fugl-Meyer Assessment. Findings from 
these studies are limited, but specific areas of improvement have been noted. Auditory-
motor coupling and entrainment, or the synchronization of rhythmic auditory stimuli with 
physical motor behaviors, appears to dominate current theoretic models. Rhythmic beats 
from external auditory sources promote gait synchronization. Temporal differences between 
movements and cues provide immediate sensory feedback on gait regularity and timing, 
allowing feed-forward adjustment and more regular, synchronous movements over time.58,109 
It is unclear whether these proposed mechanisms apply to patients with cerebellar 
stroke, with the potential to promote similar improvements in chronic motor impairments. 
A small body of research suggests that patients with cerebellar stroke are likely to benefit 
from music therapy as seen after cerebral stroke. A review of the neurobiological basis of 
rhythmic motor entrainment published by Molinari and colleagues (2003) discussed various 
cerebellar pathologies including stroke and cerebellar atrophy, and their influences on 
rhythmic and motor capabilities in patients. When asked to detect changes in frequency of a 
given auditory stimulus, patients with focal lesions (e.g. stroke patients) performed equally to 




detect the same changes. Similarly, patients with cerebellar stroke showed a capacity to tap in 
synchrony with an auditory rhythm, suggesting preserved ability to entrain external stimuli.110 
A study by Kobinata et al. (2016) explored immediate effects of RAS on gait patterns 
in 20 stoke patients, as pertained to the site of lesion (cerebellum, pons, medulla, thalamus, 
putamen, and corona radiata). Following one 20-minute session of RAS, changes in gait 
parameters were assessed and compared against pre-RAS values. Results revealed significant 
increases (p < 0.05) in velocity and stride length in patients with lesions of the cerebellum, 
pons, medulla, and thalamus. In patients with lesions of the putamen and corona radiata, no 
significant improvements were seen.64 While results of the study suggest potential benefit for 
this therapy in patients with cerebellar stroke, all participants were fewer than 94 days from 
stroke onset. Additional study limitations included a lack of a control group for comparison. 
A single case study published by Wright et al. (2016) explored the effects of rhythmic 
auditory cueing in a patient with chronic cerebellar stroke and associated gait variability. The 
patient, an 81-year old female at 12 months post-PICA infarction, had an ICARS score of 
11; abnormal gait; walking fatigue; and, recurrent falls. Cues were given over three gait trials. 
Data was obtained on gait variation (measured as coefficient of variation, CoV) and joint 
kinematics (sagittal hip, knee, and ankle angles). Gait improvements were observed, with 
reduced variability in step time, stance time, and double support time. Decreased variability 
of joint motion patterns was observed, especially during the stance phase of the gait cycle for 
hip motion, and swing phase for the knee.73 Generalization of these findings is not feasible 
with an n = 1. The findings also reflected immediate, but not long-term, therapeutic effects.   
Due to a paucity of research on music therapy, it remains unclear whether functional 
gains are 1) feasible in the chronic phase in this population; and, 2) subject to improvement 




to motor learning and integrating sensorimotor patterns affecting functional dependence, 
interventions that may reestablish these pathways, such as RAS, warrant further exploration. 
 
2.1.6 Music therapy in other movement disorders 
 
While investigations are needed to evaluate the benefits of RAS in chronic stroke 
patients and to study the effects on gait beyond the immediate time frame, observations of 
RAS in patients with other motor disorders have been promising, and suggest that there may 
be a beneficial application to patients with chronic cerebellar stroke. 
Parkinson’s Disease 
Literature on the use of RAS in Parkinson’s disease (PD) is extensive. In PD, the 
basal ganglia contain key structures that primarily affect sensory and motor learning.50,111 Like 
the cerebellum, the basal ganglia are believed to participate in rhythmic motor entrainment 
and timing through circuits interconnected with the cerebellum and cortical areas.110 Use of 
RAS in patients with PD has been associated with improvements in gait parameters similar 
to those evaluated in patients with chronic deficits relating to stroke.112,113 
An early study by Thaut et al. (1996) evaluated RAS in gait training for PD patients 
with gait deficits involving dysfunctions in velocity, stride length, and cadence. Patients were 
randomized to three conditions: an experimental group undergoing gait training with RAS; a 
self-paced group undergoing gait training without RAS; and, a control (no-training) group. 
After a three-week intervention, patients undergoing RAS training exhibited significant 
improvements in velocity on flat (p = 0.007) and inclined (p = 0.009) surfaces; cadence (p = 
0.01); and, stride length (p = 0.009). Differences in velocity and cadence were significantly 
improved compared to the self-paced group (flat: p = 0.0307; incline: p = 0.0347; cadence: p 




Work by Hausdorff et al. (2007) assessed gait changes in patients with PD compared 
to healthy controls, observing changes in gait symmetry and variability using RAS cadences 
at 100% (baseline) and 110% speeds. Immediate and 15-minute delayed effects induced by 
RAS were evaluated. At 100% speed, i.e. the pace at which patients comfortably ambulated 
prior to training, RAS produced significant increases in gait speed, stride length, and swing 
time, but did not facilitate changes in stride time or swing time variability. In contrast, RAS 
set at 110% produced significant improvements in stride length and swing time relative to 
controls (p = 0.05, p = 0.02), as well as differences in variability outcomes, compared to no-
RAS (p = 0.004, p = 0.03). An assessment of carry-over of effects revealed immediate and 
15-minute delay, sustained improvements.114 Similar findings have been echoed by multiple 
research studies, continuing support for the benefit of RAS among patients with PD.70,115 
Given the similarities of motor deficits and the localized entrainment and timing 
centers in patients with PD and cerebellar stroke, it is reasonable to consider potential 
parallel benefits in patients with chronic cerebellar stroke. Recruitment of both cerebral and 
cerebellar networks is likely required for recovery of motor function in both conditions.50  
Multiple Sclerosis 
Patients with multiple sclerosis (MS) are also hypothesized to benefit from RAS. 
Similar to PD and stroke, gait pathology in MS is linked to motor abnormalities like tremor, 
spasticity, ataxia, and loss of balance, resulting in slow, asymmetrical, fall-prone gait. In 
addition to proposed mechanisms underlying cerebellar ataxia, disruptions in sensation and 
cognition are believed to contribute to proprioceptive impairments in patients with MS.116,117  
In a three-week trial utilizing metronome-based RAS in MS patients with moderate 
gait disability, Shahraki et al. (2017) observed changes in step and stride length, cadence, gait 




implemented a protocol including cadences at both 100% and 110%. Subjects in the RAS 
group demonstrated significant improvements in stride length, stride time, cadence, and gait 
speed (p < 0.05) compared to the non-intervention group. Interestingly, groups did not 
differ in pre- and post-test double support time (p > 0.05), included as a measure of balance 
and fatigue.75 Improvements seen in MS patients undergoing RAS training were speculated 
to reflect improved coordination and gait stability. Notably, the study did not include 
patients at the most severe end of MS-related gait dysfunction,118 and further work is needed 
to determine if the observed benefits of RAS in this study might extend to all MS patients.  
Therapy with RAS also appears to facilitate motor gains in patients with cerebellar-
predominant MS. A pilot study by Baram and Miller (2007) evaluated walking speed and 
stride length in MS patients with gait disturbances and disease-induced cerebellar ataxia, 
compared to healthy controls. Outcomes were assessed during active listening, termed “on-
line” condition; and, then without RAS approximately 10 minutes later, termed “off-line.”  
Analysis of gait parameters following the study revealed improvements in speed and stride 
length for patients with MS, during on-line and off-line conditions. As expected, the healthy 
controls did not show improvement, likely due to unimpaired baseline status, but actually 
showed a decrease in gait velocity. This decrease was suspected to be related to the 
burdening effect of wearing the audio-delivery device. Though promising, results of this 
study were not evaluated for significance, and sample size was small at 14 patients, making it 
difficult to draw definitive conclusions on the utility of RAS in this population.  
Hypotheses regarding the mechanisms by which RAS facilitates gait improvement in 
patients with MS focus largely upon the reticulospinal tract, which influences muscle action 
and tone.119 Auditory cues are believed to facilitate excitability of spinal motor neurons and 




theories on the use of RAS in motor disorders, however, support for RAS in MS also credits 
RAS with entrainment of motor rhythms, provision of external cues to guide attention and 
automatic control, and motivational effects.  
Cerebral Palsy 
 RAS has been used as an approach to rehabilitation for patients with cerebral palsy 
(CP), a developmental disorder associated with neuromuscular dysfunction. Like other 
motor disorders, movements in patients with CP can be characterized by postural instability, 
muscle contractures, dyskinesia, dystonia, ataxia, and joint subluxation. Like stroke, 
manifestations of CP may be hemiplegic or spastic.120 Unlike other disorders where RAS has 
been evaluated, CP is associated with perinatal or early pediatric brain injury. Most patients 
with CP have no experience of ever having normal gait. Nonetheless, RAS appears effective 
in enhancing functional motor patterns in patients with CP, even above those benefits 
induced by standard rehabilitation techniques. 
 Work by Kim et al. (2011) evaluated RAS in patients with spastic CP, compared to 
healthy controls. Gait trials with and without RAS were implemented during a single-day 
intervention period, with outcomes addressing changes in temporospatial and kinematic 
parameters. Use of RAS ameliorated proximal joint aberrations in CP patients, compared to 
baseline recordings: pelvic anterior tilt and abnormal hip flexion in were significantly 
attenuated during RAS gait trials (p = 0.008, and p < 0.05 respectively). When subdivided by 
severity of motor impairment, patients with more severe deficits showed significant gains in 
symmetry of step length when walking with RAS (p = 0.030).79 Despite such promising 
findings, no significant differences were observed with RAS regarding gait velocity, cadence, 
step length, step time, single limb stance, double limb stance, or swing phase. Study 




 Subsequent work has shown benefits for RAS in addressing these same outcomes. In 
2012, Kim et al. explored RAS versus Bobath/neurodevelopmental (NDT) therapy in 
patients with spastic CP, over three weeks. Subjects training with RAS had improvements in 
proximal joint movement, namely pelvic tilt (p = 0.006) and hip flexion (p < 0.05). They 
showed significant gains in temporal gait parameters, such as cadence, velocity, stride length, 
and step length, (p  0.001); and decreases in stride time and step time (p = 0.001). Patients 
treated with NDT failed to achieve similar results, and actually had decreased performance in 
many of these parameters.76 While NDT was suggested to enhance postural stability in 
patients with CP, RAS appeared to be superior in enabling functional gait. While this study 
enrolled more subjects, it remains on the magnitude of a pilot study (n = 28), and had a brief 
follow-up period, which limits generalization to long-term benefits.  
 Shin and colleagues (2015) conducted a head-to-head comparison on outcomes of 
RAS over four weeks in patients with hemiplegia due to stroke or CP. Temporospatial 
parameters (cadence, velocity, step length, stride length, etc.) of the hemiplegic side failed to 
improve, while asymmetry during swing and stance phases showed significant improvement 
(p = 0.006) with RAS. Only stroke patients experienced significant benefit in kinematic 
movements such as hip adduction (p = 0.039), and distal joint mobility (p < 0.05).80 
Limitations to this study included a lack of a control group and a small sample size of n = 7 
CP patients, and n = 11 stroke patients. As such, these results do not indicate if RAS is an 
effective intervention in either study population. And, there can only be speculation on the 
mechanism or localization of pathways relating to hemispheric or spastic outcomes of injury.  
Huntington’s Disease 
 Exploration of RAS in numerous motor pathologies has generated interest in 




hereditary condition, some neurodegenerative features of HD share similarities with other 
neurodegenerative conditions such as PD.  
 Thaut et al. (1999) explored the use of RAS in HD patients, based on the theory that 
slowed movements in HD are tied to basal ganglia dysfunction, and may be ameliorated with 
RAS, similarly to patients with PD. Using metronome and music-based cues, researchers 
implemented gait trials at patients’ preferred pace, and with cues set at 10% below, and 10, 
15, or 20% above baseline speed. Except for the most disabled patients, most patients were 
able to increase velocity during metronome-cued trials (p < 0.05). Interestingly, music-based 
cueing failed to elicit the same effect. When short-term effects of RAS were evaluated in a 
follow-up, un-cued gait trial, patients showed significant retention of gait improvement (p < 
0.05) after RAS, and greater carry-over in comparison to training without RAS.77 Despite 
ability to modulate gait, however, HD patients were unable to synchronize with rhythmic 
cues, and those with more severe HD experienced greater deviations from synchrony. 
 Similar findings were reported by Bilney et al. (2005) and Delval et al. (2008). The 
former analyzed gait during self-paced and metronome-paced gait trials in 30 HD patients 
compared to controls. Results showed significant perturbations of variability in timing of 
footstep cadence for HD patients; and, inability to synchronize with cadences, compared to 
controls (p < 0.001, p < 0.01).81 Delval et al. investigated the effects of a metronome beat set 
at 120% of baseline speed on gait in HD patients, also revealing an inability to synchronize 
with given cadences. HD patients failed to exhibit increases in gait speed and cadence, in 
comparison to healthy controls (p < 0.05).121  
 Despite an ability to modulate velocity with rhythmic cues, the inability of HD 
patients to synchronize timing of gait with given cues suggests that patients may be unable to 




means to augment or replace deficient internal cueing, may indicate involvement (and 
derangement) of neural pathways separate from those implicated in other disorders.  
 
2.2 Review of relevant methods 
 
2.2.1 Study design 
 
 The proposed study is a multi-center, parallel, randomized, controlled trial to 
compare improvement of ataxia and functional status in chronic cerebellar stroke across 
patients receiving RAS versus standard of care (PT/OT) over the course of 6 months, 
beginning at least 3 months after stroke onset. 
Based on evidence suggesting poorer functional outcomes linked with hemorrhagic-
type cerebellar stroke,17,18,33 randomization into experimental and control groups will be 
stratified by stroke type (ischemic versus hemorrhagic). Randomization will be centrally 
accomplished using a computerized random selector program implemented by a computer 
specialist external to the study. Each patient will be assigned a unique study number as well 
as a computer-generated randomized treatment plan, which will be distributed by sealed 
envelopes to study personnel at each treatment facility regarding each enrolled subject. 
A multi-center design will be implemented to ensure an appropriate number of 
participants and increase generalizability of study results. Accounting for possible drop-out, 
predicted at 0-13%,83,122 target enrollment will be 840 patients. This allows for a conservative 
15% drop-out rate. A minimum sample size of n = 730 patients was determined for this 
study based on calculations for a minimal clinically important difference (MCID) of 2%, 
power of 90%, and alpha of 0.01 (2-tailed). Participants will be consecutively recruited from 
participating stroke centers and stroke rehabilitation centers, primary care providers, 




Study duration includes a recruitment period of 12 months. Treatment will be 
administered on an outpatient basis over a 6-month intervention period, beginning at a 
minimum of 90 days after stroke onset.  
 
2.2.2 Patient Selection  
 
 Eligible participants are  18 years of age with history of ischemic or hemorrhagic 
cerebellar stroke, verified by CT or MRI, with persisting associated functional impairment 
and ataxia as indicated by an mRS score of 3-5 and SARA score of 5.5 or greater, 
respectively.123 Time from stroke must be  90 days, consistent with data indicating a plateau 
in motor recovery at this time in patients treated with standard of care.37-40 Patients must be 
able to hear and/or respond to verbal stimuli. Participants must possess an appropriate level 
of alertness defined by a mini-mental state examination (MMSE) score greater than 24.87,124 
 Patients excluded from this study include those not able to meet inclusion criteria; 
those with prior neurological or communication disorders, hearing disorders, or severe 
dementia, causing an inability to meet intervention demands in experimental or standard of 
care conditions.61 Also excluded are those with visual, vestibular, or orthopedic injuries 
influencing balance and gait.21 Patients with prior hemispheric stroke are excluded to avoid 
possible confounding of results; and, patients with a pre-stroke mRS score  3 are excluded, 
as they are theoretically unable to achieve favorable post-training outcomes.105  
 
2.2.3 Clinical management 
 
Music therapy is safe and is not associated with any risks other than routine risks 
relating to PT and OT. There is no need for additional monitoring outside of pre-existing 




exercises, which may increase risk of falls in some patients. All training sessions will be 
attended by certified physiotherapists in the case that gait impairments pose risk for falls.  
 
2.2.4 Experimental Condition 
Training protocols 
 
The experimental intervention consists of gait training with RAS. Training with RAS 
will be conducted in 30-minute sessions, consistent with studies on RAS in stroke and other 
movement disorders.58,75,76,125,126 Sessions will take place at designated rehabilitation centers 
experienced in management of stroke patients. The first and last 5 minutes of each session 
will be devoted to a warm up and cool down, respectively. A warm up period of 2-5 minutes 
is believed to increase adaptability to RAS and allow practice with the delivered beat.112,127,128 
After warm up, participants will perform five, 2-minute gait trials at the determined RAS 
cadence. Each trial will be followed by a 2-minute rest period (Appendix A).  
Consistent with research on RAS in chronic stroke patients,59 preferred walking 
cadence will be determined prior to the start of gait training, using the 10-meter walking test, 
which has been recognized for high test-retest reliability in patients with stroke (ICC = 
0.87).129 The test requires participants to walk comfortably along a 5-meter pathway, forward 
and then turning to return to the starting position. The procedure is repeated twice, with 
short rests between trials. Total time is recorded for the completion of each 10-meter trial, 
omitting the time taken to turn. The average of 10-meter trials will be used to generate 
individual baseline cadence, which will be adapted to RAS protocol and accompanied by 
music – either pop or classical – according to patient preference. The test will be repeated at 
3 months and at the 6-month conclusion of the training protocol. 




Studies exploring RAS-facilitated motor benefits in patients with cerebellar stroke 
have observed greater functional improvement with delivery of beat cadences slightly above 
baseline cadence. Delivery of RAS at 110-130% cadence has been associated with significant 
motor improvements, compared to RAS at 100% (baseline) tempo.114,128 Thus, as in other 
studies using RAS in stroke patients, tempo will be sequentially increased over the course of 
the study.59,60 Training sessions will be divided into monthly blocks, with incremental 5% 
increases in rhythm frequency implemented upon the beginning of each new block as 
tolerated (Appendix B). Evaluations of mRS and SARA scores will be conducted on the final 
day of each training block, in place of normally-scheduled gait training sessions.  
Evidence that RAS may facilitate gait improvement beyond a 90-day acute period is 
supported by work by Oh et al. (2015). Researchers evaluated differences between RAS 
using music versus metronome to improve gait parameters in patients with chronic stroke. 
After four weeks of training, patients in the music group exhibited significant improvements 
in gait velocity and cadence, and deviations in body sway and functional gait assessments, 
compared to patients trained with metronome alone (p < 0.05).130 Music therapy is believed 
to involve motivational effects that may influence training adherence and outcomes. Factors 
such as familiarity and “groove” – defined as the ability of music to elicit a desire to move – 
point to motivational elements of music, producing greater tempo matching (p = 0.008) and 
gait velocity (p = 0.009) in healthy patients, versus low-familiarity, low-groove music.131 To 
incorporate these possible musical effects, RAS will be delivered through rhythmically-
accentuated music, which will be used repeatedly to ensure familiarity over the course of the 
study. Repeated use of one musical template has the additional benefit of ameliorating 
distraction associated with musical novelty, which has been suggested in studies of RAS in 




Duration of training 
Studies on RAS in hemiparetic stroke suggests increased benefits with longer training 
periods. Thaut et al. (1997) implemented RAS for a 6-week period in stroke patients during 
the acute phase, compared with stroke patients undergoing training without RAS. At the 
study conclusion, patients trained with RAS exhibited significant increases in gait velocity (p 
< 0.05), stride length (p < 0.02), and symmetrical EMG activation of the gastrocnemius (p < 
0.02).59 An identical protocol was implemented by Thaut et al. in 2007, comparing RAS to 
neurodevelopmental (NDT)/Bobath therapy, that revealed similar gait improvements in 
patients with RAS over the Bobath approach. Percentage improvements in gait parameters 
achieved over 3 weeks were subjectively less than those seen during the 6-week study, 
suggesting added motor benefits with longer duration of RAS interventions.132 Notably, both 
studies were conducted on hemiparetic stroke patients within the acute recovery phase. 
Additionally, the 6-week study was conducted in an inpatient hospital setting, with patients 
undergoing twice-daily training, five days per week, for a total of 60 sessions in 6 weeks. 
Interventions during the 3-week study were also conducted five days per week, but occurred 
just once per day, for a total of 15 sessions. This may account for the reduction in outcome. 
 This proposed study implements less frequent training sessions over a six-month 
period, to maintain patient adherence and allow time for functional gains and differences 
between treatment allocations to manifest. Most outpatient rehabilitation programs occur 
two-to-three times weekly. Gait training with RAS three times per week allows for a total of 
72 sessions over 6 months. As there is some dispute regarding the length of the acute 
recovery period, with some studies suggesting that spontaneous gains may be possible up to 
15 weeks post-stroke,133 the 6-month duration of this study allows for plateau of any residual 




effects. A 6-month intervention also allows for observation of effect trends, and evaluation 
if benefits facilitated by RAS are subject to plateau or deterioration over time.  
 
2.2.5 Control Condition 
The control condition consists of physical and occupational therapies which 
constitute the current standard of care for stroke rehabilitation. Rehabilitation therapies will 
be administered for the same amount of time as the RAS condition and will follow identical 
protocols for warm up, cool down, active training, and rest periods. Physiotherapists will be 
instructed to apply similar instructions about gait parameters to practice, but without RAS.  
 
2.2.6 Primary outcomes 
 
Ataxic symptoms will be assessed using the Scale for Assessment and Rating of 
Ataxia (SARA) while functional impairment will be measured by the Modified Rankin Scale 
(mRS). The SARA is an 8 item, 40-point performance scale of motor aberrations, with a 
total score of 0 indicating no ataxia/normal, and a score of 40 indicating most severe ataxia. 
The SARA scale has been clinically validated as a reliable measure of ataxia after stoke. It is 
directly correlated with abnormal gait status (p < 0.01) and ability to perform daily activities 
(p < 0.01).123 SARA scores under 5.5 represent minimal functional dependency, while those 
over 23 indicate total dependency.123 The ICARS scale, despite being a similarly validated 
assessment tool, was not chosen to evaluate ataxia in this study, as it has been criticized for 
difficulty due to its length, redundancy, and clinical impracticality.134 In addition, the SARA – 
but not ICARS – has been correlated with the mRS, which has been used routinely in 
chronic cerebellar stoke to describe functional status. Choi et al. (2018) evaluated the utility 
of the SARA in addressing clinical features of stroke patients at discharge, and found the 




utilized the SARA as a measure of ataxia in chronic cerebellar stroke, correlation between 
the SARA and the mRS allows for extrapolation of mRS findings in this population.  
The mRS score best serves as a measure of the primary outcome. It has been used in 
research on chronic cerebellar stroke, and has been associated with fall risk and long-term 
morbidity in stroke. Work by Callaly et al. (2015) followed stroke patients for up to 2 years 
post-stroke, describing the rates of falls, fractures, and injuries, in a prospective population-
based study. Researchers classified patients according to mRS at day 90, with mild-moderate 
disability categorized as mRS 2-3, and severe disability as mRS 4-5. Upon follow-up at 2 
years, over 30% of surviving patients had fallen, and over 60% had fallen two or more times. 
Nearly a quarter of falls resulted in fracture. Analysis by mRS categorization revealed that, of 
the total cohort, patients with mRS of 2-3 (indicating impaired mobility) had the highest risk 
of falling within two years (OR 2.3, p = 0.003). In 2-year survivors, mRS of 4-5 (functional 
dependence) was associated with the highest independent risk for falling within two years 
(OR 2.7, P = 0.003).135 The direct correlation between mRS score and both fall risk and 
mortality makes this rating an important prognostic factor. 
Prior studies in patients with chronic stroke have demonstrated RAS-facilitated 
improvements in gait patterns that translate to significant improvements in mRS-defined 
functional independence. For the mRS, the minimal clinically important difference (MCID), 
defined as the smallest change in a treatment outcome that a patient or care provider would 
consider worthwhile, has been represented as a 1-point change in mRS score.136,137 Within the 
context of post-stroke gait impairment, Tilson et al. (2010) observed that an increase in 
comfortable gait speed of at least 0.16 meters per second produced the best combination of 
sensitivity (73.9%, 95% CI = 65.9% - 80.6%) and specificity (57.0%, CI = 49.0% - 64.7%) 




implementing the six-minute walk test (6MWT) in patients at two months post-stroke. Based 
on mRS predictive value, increases in walking speed of at least 0.19 meters per second were 
correlated with improvement in mRS of 1 or more points. In patients with slower baseline 
walking speed (under 0.40 m/s), a 0.12 m/s change in speed was associated with mRS 
functional improvement.137 Use of RAS in patients with chronic cerebral stroke has induced 
changes in gait speed at this level, in excess of those facilitated by conventional 
therapy.59,60,124 It is worthwhile to note that a 1-point change in mRS does not mean that a 
patient will change categorization of functional status. For example, a patient with an mRS 
score of 5 prior to intervention, who is scored at 4 following intervention, can experience 
clinically significant improvement, but will remain in the “poor outcome” category. 
 
2.2.7 Secondary outcomes 
 
 Fall incidence over the study will be assessed as a secondary outcome. Monthly fall 
assessment will be conducted in questionnaire format at the end of each intervention block 
as part of the ataxia and functional status assessment. This will address the number of falls 
and related consequences. Definition of falls as used in prior studies is, “an event reported 
by the faller or a witness, resulting in a person inadvertently coming to rest on the ground or 
another lower level, with or without loss of consciousness or injury.”139 
 
2.2.8 Sample size rationale 
 
A sample size of 730 participants will be required to detect a 2% difference in 
proportion of patients achieving clinically significant functional improvement between RAS 
and standard of care conditions. This sample size was calculated for a two-tailed test with an 
alpha of 0.01 and beta of 0.1 to achieve a confidence level of 99% and power of 90%. A 




A 2% effect size was determined using “Minimal Clinically Important Difference,” 
(MCID) in stroke patients. In the context of stroke outcomes at 90 days, 11-15 patients, per 
1000 treated, would need to benefit (by achieving freedom from disability, as defined by an 
mRS of 0-2) for an intervention to be of significant benefit to use in clinical practice. 
Converted to a natural base value, the MCID for the mRS in the context of acute/subacute 
stroke is 1.1-1.5% of patients.140 Extrapolation of MCID to patients in the chronic phase 
allowed for the conservative determination of a 2% difference in effect for mRS outcomes.  
An attrition rate of 15% is based on adherence observed in other long-term studies 
of interventions for chronic stroke patients. Studies utilizing RAS for gait recovery in 
patients with chronic cerebral stroke have been conducted with little patient drop out, with 
attrition rates of just 1-2%.127,130 Much existing work on RAS in chronic stroke has produced 
promising outcomes, which likely contributes to patient adherence. However, many of these 
studies are conducted over periods of 4 or 6 weeks. Patient adherence to rehabilitation after 
stroke is observed to fall with time, and improvement plateau is thought to contribute to this 
pattern.141 In research by Wu et al. (2015), intensive rehabilitation therapy was compared to 
usual care in chronic stroke patients. At 12 weeks, motor benefits were seen in the intensive 
therapy group, and an attrition rate of approximately 6% was observed. At 36 weeks, motor 
gains had attenuated, and attrition had risen to nearly 13%.122 As there is an inherent attrition 
rate related to a plateau effect in improvement when using conventional rehabilitation 
techniques, a predicted attrition of 15% was assumed to match observations from other 
studies. As a note, higher attrition rates of 28% have been recorded in studies of similar 
duration, but include patient death within reasons for loss to follow up.40 Patient death most 
often occurs during the acute or subacute phase after stroke.142 As this study is designed to 





2.2.9 Estimated recruitment sites 
 
Participants will be consecutively recruited from participating tertiary stroke 
rehabilitation centers, primary care providers, neurologists, and stroke support groups, over 
the course of 12 months until adequate sample size is met. Initial contact sites are those 
within a 25-mile radius of the central data collection and processing location at the Yale 
School of Medicine, for ease of communications and management. Recruitment will be 
assessed quarterly throughout the 12-month period, with expansion of radius to include 
additional sites as needed to obtain adequate sample size. 
 
2.2.10 Confounding  
 
 Stratified randomization will be implemented to produce groups comparable at 
baseline, thus reducing the risk of confounding in the relationship between RAS and primary 
outcomes. An analysis of covariance (ANCOVA) and multivariate regression analysis will be 
included as parts of secondary analyses, to evaluate for significant external influences and 
possible confounding. Unmodifiable characteristics that may influence results that will be 
subject to secondary analysis as described, include: gender, age, education level, musical 
experience, cerebellar lesion size and location, hemorrhagic versus ischemic stroke origin, 
concurrent hemiparesis, presence of complication (edema, herniation, hydrocephalus, brain 




 The cerebellum performs a key role in neural circuits involved with sensory and 
motor function. Models of cerebellar organization postulate feed-forward and feedback 




as acquisition and automatization of motor tasks. Focal cerebellar lesions are associated with 
motor abnormalities, most classically ataxia, as well as deficits in procedural learning. These 
impairments appear to be non-resolving with time. A population of cerebellar stroke patients 
experience chronic motor deficits including ataxia, which is associated with impairments of 
gait and functionality, and increased risk of falls. Falls and mortality are associated with poor 
functional status as assessed by the Modified Rankin Scale (mRS), which clinically correlates 
with degree of ataxia as assessed by the SARA evaluation in chronic stroke.  
 Current standards of care for stroke rehabilitation including PT and OT have been 
unsuccessful in ameliorating chronic functional and motor impairments in patients following 
stroke; and, most functional gains are believed to occur within 90 days of stroke. Music 
therapy is a promising rehabilitative strategy, and evidence suggests that RAS may facilitate 
gait improvements in chronic hemiparesis in stroke patients, as well as patients with PD, MS, 
CP, and HD. There is a paucity of research evaluating the utilization of RAS in cerebellar 
stroke, and essentially none regarding RAS for cerebellar stroke in the chronic phase.  
 Observed gait improvements in subjects with vascular-related hemiparesis and motor 
deficits due to other neurological pathologies are encouraging for the use of RAS in patients 
with cerebellar stroke. The cerebellum is implicated in contributing to motor recovery in 
neurologic conditions including cerebral stroke and PD, MS, CP, and HD. But, direct injury 
to the cerebellum may negatively impact the benefits for therapy. Postulated roles of the 
cerebellum in sensorimotor learning have led some to doubt as to whether patients with 
chronic cerebellar stroke are able to acquire motor learning skills associated with RAS. The 
current study seeks to determine if there is a significant benefit to RAS therapy in facilitating 
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3.1 Study design 
 
This is a multi-center, two-group parallel randomized control trial to compare 
improvement of ataxia and functional status in chronic cerebellar stroke across patients 
receiving RAS versus standard of care (PT/OT) over the course of 6 months. 
 
3.2 Procedures and site selection 
 
Prior to the start of recruitment, IRB approval will be obtained for each 
rehabilitation training site. Approval from the IRB and Human Investigation Committee at 
Yale University will also be obtained. Eligible patients will be consecutively recruited from 
participating tertiary stroke rehabilitation centers, primary care providers, neurologists, and 
stroke support groups, over the course of 12 months until a sample size of 840 is met. 
 A letter (Appendix D) will be sent to clinical service lines (e.g. neurology services, 
primary care providers, etc.) to outline the study and encourage referral of patients who may 
be eligible for participation. Participating offices and providers will be asked to assist with 
identification and enrollment of eligible patients for the study.  
Recruitment sites will be visited by research assistants to facilitate the site enrollment 
process. Assistants will be responsible for conveying information regarding the protocol with 
physicians and staff of recruitment sites, in order to facilitate the proper identification and 
enrollment of eligible participants who meet inclusion and exclusion criteria.  
The process of patient recruitment and enrollment is illustrated by CONSORT 
diagram (Appendix E). Patients found to be potential subjects for the study will be identified 
by providers at selected recruitment sites and provided general information on the proposed 
study. If the patient is interested in participating, the research assistant will be provided with 




screening interview (Appendix F) to determine participation eligibility. Patients believed to 
be potentially eligible participants will then be scheduled for a formal evaluation of ataxia 
and functional status and determination of whether eligibility criteria is met.  
Research assistants will assist in obtaining informed consent from subjects approved 
to participate. They will facilitate communication with central study coordinators during the 
recruitment phase and will continue to relay information between study sites and central 
coordination during the intervention period, including collection of monthly patient 
outcome assessments.  
 
3.3 Study population and sampling 
 Eligible participants are  18 years of age with chronic ischemic or hemorrhagic 
cerebellar stroke defined as stroke onset  90 days prior, verified by CT or MRI, resulting in 
functional impairment and ataxia as indicated by a Modified Rankin scale score of 3-5, and a 
SARA score of 5.5 or greater. 
Eligible subjects who meet inclusion criteria and no exclusion criteria (Appendix G) 
will be provided written consent forms (Appendix H). Consent forms include study 
description, duration, potential risks and benefits, and explain that participation in the study 
is voluntary and may be terminated at any time by the patient. Consent will be obtained in 
writing. If the patient is unable to write legibly due to motor impairments associated with 
stroke, verbal consent will be obtained with a verified witness present. Consenting patients 
will be enrolled consecutively as they are identified over 12 months, with intervention and 




3.4 Subject confidentiality 
An informed consent will be obtained, which will authorize researchers to access 
personal health information (PHI) of patients. This consent will detail intended uses and 
limitations to access PHI in accordance with HIPAA regulations. Only pertinent health 
information will be reviewed and collected. All patient information used during the course of 
the study is confidential, and will be accessible only to authorized research personnel who 
have completed a HIPAA privacy training course prior to handling PHI.  
Each participant will be assigned a unique identification number upon enrollment in 
the study. All patient data, including extracted PHI and information gathered during the 
course of the study, will be labeled with this number. The key to this unique identification 
will be logged into a database to separate patient information from identity. A separate excel 
file will be created to contain unique patient identifiers and personally identifiable 
information. This file will be secured by password and network-protected firewall. All hard-
copy and paper materials will be kept in a secure central location accessible only to approved 
study personnel. At the conclusion of the study, all related documents and any PHI extracted 
will be appropriately shredded and discarded in accordance with HIPAA standards.   
 
3.5 Study variables and measures 
Dependent variables 
Primary outcomes: differences in patient ataxia scores as evaluated by the scale for 
the assessment and rating of ataxia (SARA), and level of functional independence as assessed 
by the Modified Rankin Scale (mRS). SARA scores run from 0-40, with 0 indicating no 
ataxic symptoms and 40 indicating the most severe ataxia (Appendix I). Assessments using 




and scores of 3-5 indicating “poor” functional status. A score of 6 is given in the case of 
patient death (Appendix J). Initial assessment of SARA and mRS scores will be made during 
the recruitment phase, in order to identify eligible participants, with an additional pre-
intervention assessment for enrolled patients conducted 1 week prior to the beginning of the 
intervention. Final assessments will be made on the final day of the intervention, following 6 
months of training. Differences will be calculated as pre-training minus post-training scores. 
Additional evaluations of SARA and mRS status will be made at the conclusion of each 
training month, to evaluate for possible group-by-time interaction effects.  
 A secondary outcome of fall incidence will be included. Monthly fall assessment will 
be conducted in questionnaire format, during end-of-block patient visits for SARA and mRS 
assessment, to determine number of falls and related consequences (Appendix K). 
Independent variables 
 Independent variables: the treatment arm to which the patient is assigned. Patients 
will be randomly assigned to receive gait training with RAS (treatment group), or standard of 
care consisting of PT and OT (control group).  
Other descriptive measures 
Baseline patient characteristics (Appendix L) known to be independently associated 
with the dependent variables, as well as any variables found to vary significantly between 
groups will be subject to secondary analysis of covariance (ANCOVA) and multivariate 
regression. 
 
3.6 Methodology considerations 




Gait training with RAS will be conducted by a set of board-certified music therapists 
engaged for this study, who have agreed to the delivery of therapy following specific 
protocols determined for this study (Appendix M). RAS will be delivered only to patients to 
whom they are assigned. Patients will undergo evaluation of SARA and mRS scores by 
independent, blinded assessors prior to starting RAS.  
Patients will receive three, 30-minute sessions of RAS per week over the course of 6 
months, for a total of 72 sessions. Sessions will begin within 1 week of pre-intervention 
SARA/mRS evaluation. Content of each RAS session will consist of five, 2-minute gait trials 
at a determined RAS cadence, interspersed with 2-minute rest periods between trials, and 5-
minute warm up and cool down before and after training.  
RAS sessions will be conducted at outpatient rehabilitation clinics and attended by 
physiotherapists to ensure patient safety. Patients will undergo monthly evaluations of SARA 
and mRS scores by independent, blinded assessors over the study course; the final session of 
each month will be dedicated to SARA and mRS evaluation.  
Delivery of standard of care (PT/OT) and Assessors 
 Standard of care will consist of physical therapy (PT) and occupational therapy (OT), 
provided by board-certified physical and occupational therapists. Patients will undergo 
evaluation of SARA and mRS scores by independent, blinded assessors prior to starting 
PT/OT. 
 Patients will attend three, 30-minute PT/OT sessions per week over the course of 6 
months for a total of 72 sessions. Sessions will begin within 1 week of pre-intervention 
SARA and mRS evaluation. PT and OT will be delivered according to the level and needs of 
the patient, and designed to facilitate stroke rehabilitation with focus on gait improvement, 




Ratings done throughout the study will be conducted by independent assessors.  
These assessors will be recruited to participate in the study and will be required to hold 
active board certification in physiotherapy. Assessors will rotate amongst treatment sites, so 
that no two assessments on the same patient are completed by the same assessor. Patients 
will be asked not to disclose details of their treatment to outcome assessors. Statistical 
analyses will be conducted by an independent central study coordinator, blinded to treatment 
group interventions. Patients will undergo monthly assessments using the SARA and mRS 
rating scales. At month 0, 3, and 6, the 10-meter walking test will also be administered.  
 
3.7 Randomization procedure and assignment of intervention 
Randomization into experimental and control groups will be stratified by stroke type 
(ischemic or hemorrhagic) and will be centrally accomplished using a computerized 
randomization program implemented by a computer specialist external to the study. Patients 
will be randomly assigned a unique, computer-generated random subject number that will 
also indicate their intervention group. Patients and therapists cannot be blinded to the 
intervention assignments. Research assistants will facilitate coordination with the proper 
treatment site, once the patient has been assigned to his/her treatment allocation. At each 
site, administrative staff not involved in the treatment will help to coordinate scheduling of 
treatment in the outpatient setting. Staff will also work to schedule monthly SARA and mRS 
assessments with blinded assessors who have no role in patient therapy. 
 
3.8 Blinding  
Over 6 months, patients will be administered therapy by a single physical or musical 




experience in stroke rehabilitation. Outcomes will be assessed by independent assessors 
blinded to patient group, baseline and stroke characteristics, and previous assessment scores.  
 
3.9 Adherence 
 Patients will receive communication via preferred method (text, phone call, email) 
from research assistants 3 days prior to each scheduled session as a reminder. Patient 
attendance will be recorded by scheduled therapists and research assistants. Date of session, 
duration, and clinical notes for each session will be recorded by therapists. 
 
3.10 Monitoring of adverse events 
 Patient deaths and adverse events (e.g. falls) will be assessed monthly. Failure to 
attend scheduled sessions will result in a phone call inquiry as to the cause of absence. 
Repeated failures to attend scheduled sessions or cancellation of 50% or more of scheduled 
sessions will be considered a study drop-out and the subject will be unenrolled. Failure to 
attend monthly rating sessions with independent assessors will be rescheduled within one 
week of the missed date. Absence from more than 50% of the monthly rating sessions with 
independent assessors will be considered a drop-out and the subject will be unenrolled. 
 
3.11 Data collection 
 All data will be collected within 2 years of the study start date, including the 12-
month recruitment period and 6-month training time and assessments of last recruited 
subjects. Baseline patient characteristics, stroke characteristics, and relevant hospitalization 
and therapy dates will be collected and compiled. Patient assessment scores will be entered 
into data collections as they are made available, along with information on falls or adverse 




database. Information will be transferred by an independent research associate not involved 
elsewhere in the study to transfer relevant data into a spreadsheet for statistical analysis.  
3.12 Sample size calculation 
 Sample size has been determined using an online calculator developed by Bespoke 
Statistical Services to determine a sample size sufficient to power a study at 90% with a 
confidence level of 99%. Based on research previously presented, we expect that between 
assessments at baseline and 6-months, patients undergoing standard PT and OT will not 
experience any absolute gains in ataxia (SARA) or functional independence (mRS) scores. 
Essentially, rating scores for patients in the control group are expected to remain not 
significantly improved; at baseline or worse. Based on an MCID of the mRS of 
approximately 1.1-1.5%, a conservative 2% difference in effect for patients undergoing RAS 
training is assumed. Using these values, we determine a total of 730 subjects must complete 
the primary study endpoint and be usable in analysis in order to detect an effect.  
Accounting for completion rates reported in the literature for this population, we 
expect at least 85% of patients with ataxia and functional dependence to complete the study. 
Thus, recruiting is scaled up to a total of 840 with 420 patients per arm. 
 
3.13 Analysis 
Statistical analysis will be conducted using computer-based software. The level of 
statistical significance for all tests will be set to 0.01. Analyses will be performed using an 
intention-to-treat analysis. A repeated measures ANOVA will be used to evaluate differences 
in SARA scores between groups at pre- versus post-training and during monthly evaluations 
throughout the study period. Repeated Chi square analyses will be used to assess differences 




compared between groups using a negative binomial regression model.1 These analyses will 
allow for evaluations of overall differences of effect between groups following completion of 
training interventions, and assessment of group-by-time interactions throughout the study.  
Statistical analyses will be further stratified by patient age (under 50 years old, age 50-
59, age 60-69, age 70-79, and age 80 or greater)2 and time from stroke onset (3 months to 1 
year, 1 to 2 years, and greater than 2 years).  
Baseline characteristics independently associated with the dependent variables, as 
well as any variables determined to vary significantly between groups, will be subject to post-
hoc analysis upon study completion. An analysis of covariance (ANCOVA) and multivariate 
regression analysis will be included as parts of secondary analyses, to evaluate for any 
significant external influences and possible confounding.  
 
3.14 Timeline  
Duration of the study, including patient identification and enrollment, experimental 
interventions, and data analysis, is 24 months. Recruitment will occur over a 1-year period, 
with initiation of interventions occurring on a rolling basis as patients are enrolled. All 
interventions will conclude by 1.5 years, allowing for an approximate 6-month period of time 
dedicated to data analysis and interpretation (Appendix N). 
 
3.16 Resources & Personnel  
Principle Investigators: Kaitlin Fitzgerald, PA-S; Dr. Diana Richardson, MD; Responsible 
for oversight of all operations, ensuring appropriate clinical practice and ethical soundness.  
Therapists: board-certified physical and occupational therapists, and board-certified music 
therapists familiar with the implementation of RAS will undergo training on the intervention 




they will be familiarized with study protocol. All therapists will be selected on the basis of 
comparable experience in rehabilitation of stroke patients.  
Site Primary Investigators (PI): site investigators are responsible to enroll subjects and ensure 
adherence to the protocol.  They are responsible for ensuring that all participating study 
personnel and therapists at their sites are familiar with the study protocol. Site PI will collect 
and convey study data for delivery and monitoring of interventions, as well as record 
appointment details including date of session, duration, and clinical notes. 
Research Assistants: responsible for visiting recruitment sites and conveying information 
regarding the study to medical providers/staff to facilitate identification of eligible 
participants. These individuals will provide study-related documents to participating sites; 
serve as a point of contact for study personnel; provide regular appointment reminders to 
subjects; and, conduct phone call eligibility screening. Research assistants will relay 
information between study sites and central coordination during the study period, including 
collection of monthly patient assessments and notes. They will conduct inquiries regarding 
missed appointments and monitor for minimum compliance to maintain enrollment. 
Independent Assessors: responsible for evaluation of patient SARA and mRS scores when 
determining eligibility during enrollment, at baseline, monthly during the 6-month 
intervention, and at the study conclusion. Assessors are blinded to assigned intervention 
groups, baseline symptomology, stroke localization, and previous assessment scores. 
Data Analyst: responsible for analysis of clinical data. 
HIPAA training: to be provided by Yale University to all research personnel involved in the 
access and handling of personal health information (PHI). 
Facilities: rehabilitation interventions will be conducted at enrolled outpatient rehabilitation 
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This study has several strengths. Music therapy and RAS are safe, and pose no 
additional risk to patient health over routine therapeutic interventions. RAS is inexpensive and 
can easily be incorporated into existing therapeutic practice at rehabilitation facilities. There is 
additional potential for this therapy to be conducted within the home, using self-training videos 
or telemedicine. The use of home-based media would further support utilizing electronic media 
to continue or reinforce therapeutic gains over longer periods of time. There is potential, 
therefore, for conducting long-term investigations regarding RAS techniques. 
This study is designed to minimize variables between intervention groups. This is 
achieved by stratifying randomization by stroke type and by performing an intention-to-treat 
analysis to enhance external validity and minimize bias. While this approach is sometimes 
criticized for reduction in power, this study is powered at 90%, which allows for flexibility.  
 
4.2 Disadvantages 
This study is limited by its use of convenience sampling, which is vulnerable to selection 
bias and sampling error. Another source of potential bias is that it is not feasible to conduct this 
study as a double-blinded, placebo-controlled trial. Subjects and therapists are aware that RAS is 
not the current standard of care and as such, may confer an implicit bias affecting participation. 
Conversely, there is potential for enhanced placebo effect from the therapy due to anticipated 
benefit, which would promote greater effort from subjects and therapists. The use of blinded 
assessors attempts to mitigate this potential source of bias. With regards to falls, patient self-
reporting introduces potential for recall bias or selective reporting. In this study, it is suspected 
that this might be applicable equally between the two groups. Finally, due to the 2-year duration 




addressed within the scope of this study. There is, therefore, potential for additional 























Appendix A: Single Session RAS Gait Training Protocol 
 
 
Time (minutes) Activity 
5 Warm-up  
2 RAS training 
2 Break 
2 RAS training 
2 Break 
2 RAS training 
2 Break 
2 RAS training 
2 Break 
2 RAS training 
2 Break 
5 Cool down 











*T = serial, end of month evaluations of mRS and SARA scores 














Appendix D: Letter to Clinical Service Lines 
 
To Whom It May Concern: 
 
We are writing to inform you about an upcoming clinical trial which may be an exciting opportunity 
to provide new rehabilitative options to patients with chronic ataxia following cerebellar stroke. We 
would like to offer you the opportunity to refer your patients to participate in this trial, which explores 
the effect of rhythmic auditory stimulation (RAS) compared against standard of care (physical and 
occupational therapies) in stroke rehabilitation for patients with chronic ataxia and functional 
impairment.  
 
For this study, we are recruiting 840 patients who experienced cerebellar stroke at least 3 months ago, 
and who have persisting ataxic symptoms influencing functional independence. Our inclusion and 
exclusion criteria is listed below: 
 
Exclusion 
- Prior neurological or communication 
disorder  
- Hearing disability or disorder precluding 
recognition of auditory stimuli 
- Premorbid mRS 3 
- Premorbid SARA 5.5 
- Prior hemispheric or brainstem stroke 
- Inability to meet demands of intervention 
- Severe dementia or MMSE < 24 
- Visual, vestibular, orthopedic, or other 
impairment influencing balance and gait 
 
 
We have enclosed in this letter the patient consent form detailing study design, eligibility, and 
expectations for participation. We hope that you will take a few moments to review these materials and 
consider referring patients you believe may be eligible for this clinical study. If you, after having 
reviewed these materials, are interested in referring patients to this study, we will arrange an in-person 
visit to your place of work to discuss any further details or questions you may have.  
 
Please ensure all information provided to you relating to this clinical trial is treated with strict 
confidentiality.  Please feel free to contact me if you would like further information about the trial and 
the potential participation of your patients in the trial. 
 
Thank you for your consideration. 
 
Yours sincerely, 
Kaitlin Fitzgerald  
 




- Age  18 years 
- History of CT or MRI-verified ischemic or 
hemorrhagic cerebellar stroke  
- Modified Rankin Scale (mRS) score 3-5 
- Scale for the Assessment and Rating of 
Ataxia (SARA) score  5.5 
- Onset of stroke  3 months ago 
- Able to hear/respond to auditory stimuli 
and verbal instruction 
- Mini-mental state examination (MMSE) 











Appendix F: Structured Phone Call Screening Interview  
 
Hello Mr./Mrs. _______,  
 
We are calling you to discuss an upcoming clinical trial which may be an exciting opportunity 
to provide new rehabilitative options to patients with chronic ataxia following cerebellar stroke. We 
have been informed by ______ that you may be an eligible subject for participation in this trial and 
that, after receiving information on the study, you have expressed interest in participating.  
 
 Before we schedule an in-person assessment and evaluation for eligibility, we would like to 
discuss aspects relating to the study over the phone.  
 
1. How old are you? 
a. Patient must be at least 18 years of age 
2. How long ago was your stroke? 
a. Stroke onset must be at least 3 months prior 
3. How would you describe your level of disability prior to experiencing stroke? 
a. No or minimal disability  
b. Some disability: I was able to walk unassisted (without assistive device/person), but 
I needed some help in looking after my own affairs and carrying out my previous 
activities  
c. Moderate disability: I was unable to walk unassisted, and I needed help managing 
my daily bodily needs  
d. Severe disability: I needed constant nursing care and attention, I was bedridden 
 
Patients with no or minimal disability prior to stroke are eligible for participation 
Patients with greater than no or minimal disability prior to stroke are ineligible 
for participation 
 
4. How would you describe your level of disability presently? 
a. No or minimal disability  
b. Some disability: I am able to walk unassisted, but I need some help in looking after 
my own affairs and carrying out my previous activities  
c. Moderate disability: I am unable to walk unassisted, and I need help managing my 
daily bodily needs  
d. Severe disability: I need constant nursing care and attention, I am bedridden 
 
Patients with no or minimal disability are ineligible for participation.    
Patients with some or moderate disability are eligible for participation.  
Patients with severe disability may be eligible if able to fulfill therapeutic 
requirements 
 
5. Exclusion criteria: 
a. Do you have any underlying neurological or communication disorders? 
i. Patients with underlying neurological or communication disorders 
are ineligible for participation 
b. Do you have a hearing disability that might interfere with listening to music? 
i. Patients with a hearing disability that might interfere with listening 
to music are ineligible for participation 
c. Have you experienced any other strokes? If yes, do you know which area of the 




i. Patients with prior cerebral or brainstem strokes are ineligible for 
participation 
d. Have you ever been diagnosed with dementia? 
i. Patients with severe dementia are ineligible for participation 
e. Do you have any visual, vestibular, orthopedic, or other impairments that affect 
balance and ability to walk? 
i. Patients with visual, vestibular, orthopedic, or other impairments that 
affect balance and ability to walk are ineligible for participation 
 
For patients who meet exclusion criteria: 
 Unfortunately, it appears that you do not fit the criteria we’ve outlined for the current study. 
We encourage you to check in regularly with your provider about upcoming opportunities for 
participation in other research studies, and wish you the best in your healthcare journey.  
 
For patients who do not meet exclusion criteria: 
It appears that you may meet the criteria we’ve outlined for the current study. We would like 








Appendix G: Inclusion and Exclusion Criteria 
 
 
Inclusion  Exclusion 
Age  18 years Prior neurological or communication disorder  
History of CT or MRI-verified ischemic or 
hemorrhagic cerebellar stroke  
Hearing disability or disorder precluding recognition 
of auditory stimuli 
Modified Rankin Scale (mRS) score 3-5 Premorbid mRS 3 
Scale for the Assessment and Rating of Ataxia 
(SARA) score  5.5 
Premorbid SARA 5.5 
Onset of stroke  90 days ago Prior hemispheric or brainstem stroke 
Able to hear/respond to auditory stimuli and verbal 
instruction 
Inability to meet demands of intervention 
Mini-mental state examination (MMSE) score  24 Severe dementia or MMSE < 24 
  Visual, vestibular, orthopedic, or other impairment 





Appendix H: Informed Consent Forms  
 
COMPOUND AUTHORIZATION AND CONSENT FOR PARTICIPATION IN A 
RESEARCH STUDY 
 
YALE UNIVERSITY SCHOOL OF MEDICINE 
 
 
Study Title: Efficacy of Rhythmic Auditory Stimulation on Ataxia and Functional Dependence 
Post-Cerebellar Stroke 
 
Principal Investigator: Kaitlin Fitzgerald, PA-SII; Diana Richardson, MD 
Phone Number: 999-999-9999  
Funding: to be determined 
 
 
Invitation to Participate and Description of Project 
You are invited to participate in a research study evaluating whether the use of rhythmic 
auditory stimulation (RAS) therapy will help improve motor difficulties in patients after cerebellar 
stroke. This is designed to treat both chronic difficulties when performing usual daily activities 
(known as function deficits) and unsteady irregular walking (known as gait ataxia). We will be 
comparing rhythmic auditory stimulation (RAS) therapy to standard rehabilitation techniques used 
during recovery after strokes. The objective of this study is to determine the effectiveness of RAS as 
a motor rehabilitation approach for patients with chronic cerebellar difficulties, and to facilitate 
further improvement of walking and performance of daily activities.  
Little is known about how strokes change the function of the cerebellum, but it is believed 
that patients who suffer from stroke regain little functionality beyond the first three months post-
stroke. It is known that the use of standard rehabilitative techniques such as physical and 
occupational therapy help in recovery of some of the cerebellar function. There is a substantial body 
of work supporting newer therapy techniques such as RAS in patients with motor disorders including 
impairments seen following stroke. We believe that RAS may be of equal or greater benefit for 
helping to improve recovery of functional independence and gait in patients who have chronic 
cerebellar stroke symptoms.  
This consent form will provide detailed information about the research study. A member of 
the research team will review the form with you and answer any questions that you may have about 
the study. They will discuss all parts of the research, its purpose, procedures, any risks, and possible 
benefits. Take as much time as you need before you make your decision. After learning about the 
study, if you wish to participate, you will be asked to sign this form. 
 
Description of procedures 
Individuals who choose to participate in this study will be randomly assigned to the 
intervention group receiving RAS, or to the standard of care group receiving more traditional 
physical and occupational therapy. Training sessions will take place at selected sites staffed by 
certified therapists (physical, occupational and music therapists). The time dedicated to the study is 
the same for participants in both treatment groups.  
Each participant will participate in pre-determined therapy techniques based on their 
assigned intervention group. Therapy sessions will be conducted three times per week over 6 
months, for a total of 72 sessions. Each session will take approximately 30 minutes. Pre- and post-
training assessments of gait and functionality will be performed prior to the start of training, and on 




This study involves frequent training visits to participate in rehabilitation. You will receive 
communication via preferred method (text, phone call, email) from research assistants 3 days prior to 
each scheduled session as a reminder. 
 
Why is this study being offered to me? 
You are being asked to participate in this study because you have a prior diagnosis of 
cerebellar stroke occurring at least 3 months ago, and have experienced associated persistent 
impairments in functional independence and gait. We are looking for 840 participants to be part of 
this research study.  
 
Risks 
There are no special or anticipated increased risks associated with RAS as a therapeutic 
modality. Like other rehabilitative techniques, therapy using RAS involves motor training and 
exercises, which may increase risk in falls in some patients. A certified physiotherapist will be present 
during all training sessions to prevent and to provide care in the event of a fall.  
 
Benefits 
Benefits of the study may include improvement in functional status and enhanced recovery 
of normal gait. Improvements in gait are associated with decreased risk of falling and fall-associated 
consequences, including death. Information collected from you during the study may help us to 
better understand the nature of cerebellar stroke, and may highlight new paths for treatment during 
the chronic phase of recovery, as this is a period of time well-recognized as one in which few 
functional improvements are gained with standard rehabilitation approaches.  
 
Economic considerations 
 There is no cost to you or your health insurance provider for participation in this study. You 
will be compensated for costs of travel and parking associated with training visits.   
 
Treatment alternatives  
 One alternative to this study is not to participate. You may also choose to pursue other 
rehabilitation techniques, which may or may not facilitate personal motor recovery.  
 
Voluntary participation 
Taking part in this study is your choice. You can choose to take part, or you can choose not 
to take part in this study. Should you decided to participate in this study, you can also change your 
mind at any time. Whatever choice you make, you will not lose access to your medical care or give up 
any legal rights or benefits. 
 
Confidentiality 
Throughout the course of this study, all information collected about you will be kept 
confidential, and only accessible by a number assigned to you upon enrollment. In accordance with 
HIPAA regulations, only relevant health information will be reviewed and collected from your 
records for the purpose of this study. All information used during the course of the study is 
confidential, and will be accessed only be individuals authorized by study and with completion of 
certified HIPAA privacy training course through Yale University.  
To ensure security of participants’ data, all digital information is to be stored on a secure 
computer server. All hard-copy and paper materials will be kept in a secure central location accessible 
only by approved study personnel. All identifying health information extracted as part of the study 
will be destroyed following conclusion of the study, rendering the data anonymous. It is possible that 
this anonymous data may be used in subsequent research or distributed to another investigator for 




Any personal health information or identifiable information obtained in connection with this 
study will remain confidential except in the event that you wish to disclose it, or its release is required 
by state or federal law.  
 
What Information Will You Collect About Me in this Study? 
 The information we are asking to use and share is called “Protected Health Information.” It is 
protected by a federal law called the Privacy Rule of the Health Insurance Portability and 
Accountability Act (HIPAA). In general, we cannot use or share your health information for research 
without your permission. If you want, we can give you more information about the Privacy Rule. If 
you have any questions about the Privacy Rule and your rights, you can speak to Yale Privacy Officer 
at 203-432-5919. 
 
The specific information about you and your health that we will collect, use, and share includes: 
• Research study records 
• Medical/laboratory records of services provided in connection with this study 
• Research records and medical records created during the study 
• Records about phone calls, texts, or email communications made as part of this research 
• Records about your study visits 
• Information obtained during this research regarding 
o New or worsening motor function 
o Falls and fall-associated consequences 
o Relevant physical exam and test results  
o Diagnosis and management of new health conditions 
 
How will you use and share my information? 
We will use your information to conduct the study described in this consent form.  
We may share your information with: 
• The U.S. Department of Health and Human Services (DHHS) agencies 
• Representatives from Yale University, the Yale Human Research Protection Program and the 
Institutional Review Board (the committee that reviews, approves, and monitors research on 
human participants), who are responsible for ensuring research compliance.  These individuals 
are required to keep all information confidential.  
• Health care providers who provide services to you in connection with this study 
• Laboratories and other individuals and organizations that analyze your health information in 
connection with this study, according to the study plan 
• Co-Investigators and other investigators  
• Study coordinators and members of the research team  
• Data and safety monitoring boards and others authorized to monitor the conduct of the study  
 
We will do our best to make sure your information stays private. But, if we share information with 
people who do not have to follow the Privacy Rule, your information will no longer be protected by 
the Privacy Rule. Let us know if you have questions about this. However, to better protect your health 
information, agreements are in place with these individuals and/or companies that require that they 
keep your information confidential. 
 
Why must I sign this document? 
 By signing this form, you will allow researchers to use and disclose your information described 
above for this research study. This is to ensure that the information related to this research is available 
to all parties who may need it for research purposes. You always have the right to review and copy 






What if I change my mind? 
 The authorization to use and disclose your health information collected during your 
participation in this study will never expire.  However, you may withdraw or take away your permission 
at any time. You may withdraw your permission by telling the study staff or by writing to Kaitlin 
Fitzgerald at 999 Yale University, New Haven, CT 06520. 
 If you withdraw your permission, you will not be able to stay in this study but the care you get 
from your doctor outside this study will not change.  No new health information identifying you will 
be gathered after the date you withdraw. Information that has already been collected may still be used 
and given to others until the end of the research study to ensure the integrity of the study and/or study 
oversight.   
 
What if I want to refuse or end participation before the study is over?  
Taking part in this study is your choice. You can choose to take part, or you can choose not 
to take part in this study.  You also can change your mind at any time.  Whatever choice you make, 
you will not lose access to your medical care or give up any legal rights or benefits.  
We would still treat you with standard therapy or, at your request, refer you to a clinic or 
doctor who can offer this treatment. Not participating or withdrawing later will not harm your 
relationship with your own doctors or with this institution.   
To withdraw from the study, you can call a member of the research team at any time and tell 
them that you no longer want to take part.   
 
 
What will happen with my data if I stop participating? 
Should you choose to withdraw from this study before its completion, data derived during 
the course of research will be de-identified and thus, rendered anonymous. Data will be unable to be 
withdrawn.  
 
Who should I contact if I have questions?  
 
Please feel free to ask about anything you don't understand.  
 
If you have questions later or if you have a research-related problem, you can call the Principal 
Investigators Kaitlin Fitzgerald, PA-S or Diana Richardson, MD at 999-999-9999.   
 
If you have questions about your rights as a research participant, or you have complaints about this 
research, you can call the Yale Institutional Review Board at (203) 785-4688 or email hrpp@yale.edu. 
 
A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as required by U.S. 
Law. This Web site will not include information that can identify you. At most, the web site will 
include a summary of the results. You can search this web site at any time. 
 
Authorization and Permission 
 
Your signature below indicates that you have read this consent document and that you agree to be in 
this study.   
 






Participant Printed Name  Participant Signature  Date 
Person Obtaining Consent Printed 
Name 




Complete if the participant is not able to write legibly. This form should be signed by the research 
assistant delivering information about the research study, as well as a witness.  
 
Print name of research assistant: ___________________________________ 
 
Signature of research assistant: ________________________________    Date: _________ 
 
An oral translation of this document was administered to the participant by a research 
assistant proficient in English.  
Print name of impartial witness: __________________________________ 
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Appendix K: Patient Fall Questionnaire  
 
 
Patient No: ________ 
Date: _________ 
Training site: ______________ 
Name of assessor: ________________ 
 
What is a fall? 
A fall is an event reported by the faller or a witness, resulting in a person inadvertently 
coming to rest on the ground or another lower level, with or without loss of consciousness 
or injury.  
 
1. In the last 4 weeks, have you experienced a fall?   Yes  No 
2. If you fell more than once in the last 4 weeks, how many times did you fall? ______ 
 
3. Did you lose consciousness during the event(s)?  Yes  No 
4. Did your fall(s) result in injury requiring medical evaluation (e.g. fractures, 
concussion, bleeding in the brain)?  






Appendix L: Patient Baseline Characteristics 
 
Baseline Characteristics RAS (n = 420) Control (n = 420) 
Age (years)   
     Under 50 Number, % Number, % 
     50-69 Number, % Number, % 
     60-69 Number, % Number, % 
     70-79 Number, % Number, % 
     80 or greater Number, % Number, % 
Sex   
     Male Number, % Number, % 
     Female Number, % Number, % 
Education level Median years ± IQR* Median years ± IQR 
Prior musical experience   
     Yes Number, % Number, % 
     No Number, % Number, % 
MMSE* score Mean score ± SD* Mean score ± SD 
Age at stroke onset   
     Under 50 Number, % Number, % 
     50-69 Number, % Number, % 
     60-69 Number, % Number, % 
     70-79 Number, % Number, % 
     80 or greater Number, % Number, % 
Time since stroke onset   
     3-12 months Number, % Number, % 
     1-2 years Number, % Number, % 
     2 years or greater Number, % Number, % 
Stroke type   
     Hemorrhagic Number, % Number, % 
     Ischemic Number, % Number, % 
Vascular territory impacted   
     AICA* Number, % Number, % 
     PICA* Number, % Number, % 
     SCA* Number, % Number, % 
     2 vascular territories  Number, % Number, % 
     3 or more vascular territories Number, % Number, % 
Lesion size (cm2) Mean size ± SD Mean size ± SD 
Concurrent hemiparesis   
     Yes Number, % Number, % 
     No Number, % Number, % 
Presence of complication    
     Edema Number, % Number, % 
     Herniation Number, % Number, % 
     Hydrocephalus Number, % Number, % 
     Brain stem involvement Number, % Number, % 
     Other Number, % Number, % 
Surgical intervention    
     Yes Number, % Number, % 
     No Number, % Number, % 
Length of inpatient stay (days) Mean time ± SD Mean time ± SD 
*MMSE: mini-mental state examination, *AICA: anterior inferior cerebellar artery, *PICA: posterior 
inferior cerebellar artery, *SCA: superior cerebellar artery 




Appendix M: Rhythmic Auditory Stimulation (RAS) Treatment Protocol 
 
Prior to training 
Upon participant arrival, ensure that patients have proper training equipment (supportive 
footwear, non-restrictive clothing, etc.) and are ready to begin training. 
An accompanying physiotherapist must be present for the duration of the training session.  
 
Prior to the start of training, provide patients with an MP3 player and headphones for the 
delivery of personalized-cadence music at a comfortable volume.  
 
Therapists must document patient training information, including discontinuation or pausing 
of gait trials for any reasons, adverse events, patient complaints, and clinical notes.  
 
Training time: 30 minutes 
 
5 minutes: Warm Up  
- Instruct patients to begin listening to provided music at the beginning of 
training/warm-up 
- Participants will be seated in a chair for the warm up  
- Ask patients to tap their feet, nod their heads, and/or march in place in time with the 
cadence of the delivered beat 
 
20 minutes: RAS training blocks (5, 2-minute trials) and breaks (5, 2-minute breaks) 
- During delivery of RAS training, instruct patients to walk along a flat surface while 
matching his/her footfalls to the musical beat delivered through the MP3 player  
o Patients who feel unable to complete a trial due to fatigue, unsteadiness, 
dizziness, or other reason may discontinue the present gait trial. If 
comfortable and able, he/she may resume training as desired.  
o If patients are unable to match the delivered cadence, lower the delivered 
cadence to the most recent, highest, successfully-matched cadence. 
- During breaks, patients should be asked to sit or stand comfortably 
 
5 minutes: cool down 
- Participants will be seated in a chair for the cool down  
- Ask patients to tap their feet, nod their heads, and/or march in place in time with the 
cadence of the delivered beat 
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